Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
January 31 2024
medRxiv
COVID-19
Providing top-tier insights for research and publications